Pharma Grip Archives

6 Most Important Elements for Business Continuity Plan for cGXP Computerised Systems

Rajat Shrivastava February 25, 2021

Hello Everyone, Welcome to PharmaGrip (LyfnStyle.Com) Today we are with you to discuss the 6 Most Important Elements for Business Continuity Plan for cGXP Computerised…

Integrity Testing of HEPA Filter | DOP Testing | PAO Testing

Rashi Shrivastava February 8, 2021

Hello Everyone. What’s up? Welcome to Queries Shadow! This article is about the Integrity Testing of HEPA Filter | DOP Testing | PAO Testing. DOP…

Top 5 Common cGXP Error related to Validation activity of GXP computerized systems in Pharma Industries

Rajat Shrivastava February 6, 2021

Hello Everyone, Welcome to PharmaGrip Today we will discuss some common errors related to computerized systems made by the pharmaceutical industries. Top 5 Common cGXP…

7 Objective for Regulatory Streamlined Approach for Pharmaceutical Manufacturing Facilities & Equipment (21 CFR Part 211).

Rajat Shrivastava January 29, 2021

Hello Everyone, Welcome to Pharm grip. Let’s go through the 7 Objective for Regulatory Streamlined Approach for Pharmaceutical Manufacturing Facilities & Equipment (21 CFR Part…

A Brief History of GMP | When Was GMP Introduced in The World | Why do We Need GMP?

Rajat Shrivastava January 15, 2021

Hello Everyone, Welcome to LyfnStyle.com Pharma Grip Section Today we will be talking about the A Brief History of GMP | When Was GMP Introduced…

How to Avoid Such Unfortunate FDA Warning Letter | Case Study of Market Complaint

Rajat Shrivastava January 4, 2021

Hello Everyone. In this article, we will share about How to Avoid Such Unfortunate FDA Warning Letter | Case Study of Market Complaint Failing to…

What is the difference between GMP, GDP, FDA, CEP, and more certifications in pharma?

Different Types of Certifications in Pharma | GMP, GDP, FDA, CEP, More

Rajat Shrivastava December 18, 2020

Pharma Companies Will Invest Millions Of Dollars In Order to Get It, But If They Lose It, It Will Probably Cost Them Even More. What…

Investigation of OOS Case Study on Microbial Test | FDA Warning Letter

Rajat Shrivastava December 16, 2020

Failing to investigate an out-of-specification result adequately can easily earn you a warning letter. A case study on Investigation of OOS Case Study on Microbial…

3 Step How Do We Protect Our Antibiotic Resistance

Rajat Shrivastava November 17, 2020

Antibiotics are some of our most precious medicines and we’re going to lose them unless we protect them so spread the word. Let’s start knows…

How to register an Investigational New Drug (IND) to US | 4 Steps Guide

Rajat Shrivastava October 24, 2020

Welcome to Quires Shadow Today I am sharing with you How to register an Investigational New Drug (IND) to US | 4 Steps Guide. Are…

LyFnStyle

Category: Pharma Grip

6 Most Important Elements for Business Continuity Plan for cGXP Computerised Systems

Integrity Testing of HEPA Filter | DOP Testing | PAO Testing

Top 5 Common cGXP Error related to Validation activity of GXP computerized systems in Pharma Industries

7 Objective for Regulatory Streamlined Approach for Pharmaceutical Manufacturing Facilities & Equipment (21 CFR Part 211).

A Brief History of GMP | When Was GMP Introduced in The World | Why do We Need GMP?

How to Avoid Such Unfortunate FDA Warning Letter | Case Study of Market Complaint

Different Types of Certifications in Pharma | GMP, GDP, FDA, CEP, More

Investigation of OOS Case Study on Microbial Test | FDA Warning Letter

3 Step How Do We Protect Our Antibiotic Resistance

How to register an Investigational New Drug (IND) to US | 4 Steps Guide